• Landos Biopharma Secures $60M Financing, Continues BT-11 Development for IBD
  • TB or Not TB? Addressing the Tuberculosis Question
  • Eli Lilly Launches Challenge for Digital Solutions to Improve IBD Care
  • Smoking Does Not Have Beneficial Effects for UC Patients, Study Shows
  • Failing to Prepare Is Preparing to Fail
  • A Low-residue Diet Has Helped with My Crohn’s Symptoms
  • IBD Patients at Higher Risk of Developing Type 2 Diabetes, Study in Denmark Suggests
  • NP-178 Becomes Algernon’s Lead Candidate for Treating IBD
  • Loving My Body When My Body Doesn’t Love Me
  • Edinburgh has One of the Highest Rates of IBD in the World, Study Reports
  • Malnutrition Is Common in Life with Crohn’s Disease
  • Camligo Trial Yields Mixed Results in Patients with Pouchitis